Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 557

1.

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex.

Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, van der Vaart T, Jansen FE, Elgersma Y, Moll HA, de Wit MY; ENCORE Expertise Centre for Neurodevelopmental Disorders.

Neurology. 2019 Jul 9;93(2):e200-e209. doi: 10.1212/WNL.0000000000007749. Epub 2019 Jun 19.

PMID:
31217257
2.

"Be an ambassador for change that you would like to see": a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease.

Ambrosini A, Quinlivan R, Sansone VA, Meijer I, Schrijvers G, Tibben A, Padberg G, de Wit M, Sterrenburg E, Mejat A, Breukel A, Rataj M, Lochmüller H, Willmann R; 235th ENMC workshop study group.

Orphanet J Rare Dis. 2019 Jun 7;14(1):126. doi: 10.1186/s13023-019-1103-8.

3.

Mucilage powder from cactus pears as functional ingredient: influence of cultivar and harvest month on the physicochemical and technological properties.

Du Toit A, De Wit M, Fouché HJ, Taljaard M, Venter SL, Hugo A.

J Food Sci Technol. 2019 May;56(5):2404-2416. doi: 10.1007/s13197-019-03706-9. Epub 2019 Mar 25.

PMID:
31168123
4.

Physicians' Perspectives on Person-Related Factors Associated With Work Participation and Methods Used to Obtain Information About These Factors.

de Wit M, Wind H, Snippen NC, Sluiter JK, Hulshof CTJ, Frings-Dresen MHW.

J Occup Environ Med. 2019 Jun;61(6):499-504. doi: 10.1097/JOM.0000000000001596.

PMID:
31167222
5.

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.

Leung YY, Orbai AM, Ogdie A, Coates LC, de Wit M, Callis Duffin K, Eder L, Gladman DD, Goel N, Mease PJ, Strand V, FitzGerald O, Tillett W.

J Rheumatol Suppl. 2019 Jun;95:33-37. doi: 10.3899/jrheum.190122.

PMID:
31154402
6.

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting.

Jadon DR, Chandran V, Ogdie A, Pennington SR, Stober C, Gladman DD, de Wit M, O'Sullivan D, Mease P, Armstrong AW, Callis Duffin K, Magee C, Helliwell P, Ritchlin CT, FitzGerald O.

J Rheumatol Suppl. 2019 Jun;95:11-19. doi: 10.3899/jrheum.190118.

PMID:
31154399
7.

Response to Wollschläger, Blettner, and Pokora.

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.

J Natl Cancer Inst. 2019 Apr 12. pii: djz062. doi: 10.1093/jnci/djz062. [Epub ahead of print] No abstract available.

PMID:
31131847
8.

Decision aids that facilitate elements of shared decision making in chronic illnesses: a systematic review.

Wieringa TH, Rodriguez-Gutierrez R, Spencer-Bonilla G, de Wit M, Ponce OJ, Sanchez-Herrera MF, Espinoza NR, Zisman-Ilani Y, Kunneman M, Schoonmade LJ, Montori VM, Snoek FJ.

Syst Rev. 2019 May 20;8(1):121. doi: 10.1186/s13643-019-1034-4.

9.

Obtaining person-related information from employees with chronic health problems: a focus group study.

de Wit M, Wind H, Hulshof CTJ, de Boer AGEM.

Int Arch Occup Environ Health. 2019 May 18. doi: 10.1007/s00420-019-01440-5. [Epub ahead of print]

PMID:
31104126
10.

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients.

Vleugels JLA, van Neerven SM, van Leerdam ME, Wanders LK, de Wit M, Carvalho B, Delis-van Diemen PM, Kallenberg FGJ, Vermeulen L, Beliën JA, East JE, Meijer GA, Dekker E.

Endosc Int Open. 2019 May;7(5):E701-E707. doi: 10.1055/a-0832-8283. Epub 2019 May 8.

11.

Antagonizing Increased miR-135a Levels at the Chronic Stage of Experimental TLE Reduces Spontaneous Recurrent Seizures.

Vangoor VR, Reschke CR, Senthilkumar K, van de Haar LL, de Wit M, Giuliani G, Broekhoven MH, Morris G, Engel T, Brennan GP, Conroy RM, van Rijen PC, Gosselaar PH, Schorge S, Schaapveld RQJ, Henshall DC, De Graan PNE, Pasterkamp RJ.

J Neurosci. 2019 Jun 26;39(26):5064-5079. doi: 10.1523/JNEUROSCI.3014-18.2019. Epub 2019 Apr 23.

PMID:
31015341
12.

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

de Wit M, Cooper C, Tugwell P, Bere N, Kirwan J, Conaghan PG, Roberts C, Aujoulat I, Al-Daghri N, Araujo de Carvalho I, Barker M, Bedlington N, Brandi ML, Bruyère O, Burlet N, Halbout P, Hiligsmann M, Jiwa F, Kanis JA, Laslop A, Lawrence W, Pinto D, Prieto Yerro C, Rabenda V, Rizzoli R, Scholte-Voshaar M, Vlaskovska M, Reginster JY.

Aging Clin Exp Res. 2019 Jul;31(7):905-915. doi: 10.1007/s40520-019-01193-8. Epub 2019 Apr 16. Review.

13.

Response.

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.

J Natl Cancer Inst. 2019 Apr 12. pii: djz062. doi: 10.1093/jnci/djz062. [Epub ahead of print] No abstract available.

PMID:
30977817
14.

Web-Based Multidomain Lifestyle Programs for Brain Health: Comprehensive Overview and Meta-Analysis.

Wesselman LM, Hooghiemstra AM, Schoonmade LJ, de Wit MC, van der Flier WM, Sikkes SA.

JMIR Ment Health. 2019 Apr 9;6(4):e12104. doi: 10.2196/12104. Review.

15.

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

Chiarotto A, Kaiser U, Choy E, Christensen R, Conaghan PG, Cowern M, Gill M, de Wit M, Gargon E, Horgan B, Kirkham JJ, Simon LS, Singh JA, Tugwell P, Turk DC, Mease PJ.

J Rheumatol. 2019 Apr 1. pii: jrheum.181099. doi: 10.3899/jrheum.181099. [Epub ahead of print]

PMID:
30936284
16.

Practical guidance for patient-centred health research.

de Wit M, Cooper C, Reginster JY; WHO-ESCEO Working Group.

Lancet. 2019 Mar 16;393(10176):1095-1096. doi: 10.1016/S0140-6736(19)30034-0. Epub 2019 Mar 14. No abstract available.

PMID:
30894262
17.

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

Smith TO, Mansfield M, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Mar 1. pii: jrheum.181066. doi: 10.3899/jrheum.181066. [Epub ahead of print]

PMID:
30824657
18.

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.

Duarte-García A, Leung YY, Coates LC, Beaton D, Christensen R, Craig ET, de Wit M, Eder L, Fallon L, FitzGerald O, Gladman DD, Goel N, Holland R, Lindsay C, Maxwell L, Mease P, Orbai AM, Shea B, Strand V, Veale DJ, Tillett W, Ogdie A.

J Rheumatol. 2019 Feb 15. pii: jrheum.181089. doi: 10.3899/jrheum.181089. [Epub ahead of print]

PMID:
30770518
19.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Feb 15. pii: jrheum.181096. doi: 10.3899/jrheum.181096. [Epub ahead of print]

PMID:
30770515
20.

Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.

Humphrey-Murto S, Crew R, Shea B, Bartlett SJ, March L, Tugwell P, Maxwell LJ, Beaton D, Grosskleg S, de Wit M.

J Rheumatol. 2019 Feb 15. pii: jrheum.181094. doi: 10.3899/jrheum.181094. [Epub ahead of print]

PMID:
30770512
21.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Feb 15. pii: jrheum.181097. doi: 10.3899/jrheum.181097. [Epub ahead of print]

PMID:
30770502
22.

Suboptimalities for sure: Arguments from evolutionary theory.

Withagen R, van der Kamp J, de Wit M.

Behav Brain Sci. 2018 Jan;41:e247. doi: 10.1017/S0140525X18001322.

PMID:
30767823
23.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.

Toupin-April K, Barton JL, Fraenkel L, Meara A, Li LC, Brooks P, de Wit M, Stacey D, Légaré F, Shea B, Lyddiatt A, Hofstetter C, Christensen R, Scholte Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Karuranga S, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Beaton D, El-Miedany Y, Mittoo S, Bartlett SJ, Singh JA, Tugwell PS.

J Rheumatol. 2019 Feb 1. pii: jrheum.181071. doi: 10.3899/jrheum.181071. [Epub ahead of print]

PMID:
30709963
24.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Feb 1. pii: jrheum.181218. doi: 10.3899/jrheum.181218. [Epub ahead of print]

PMID:
30709952
25.

Vibration isolation with high thermal conductance for a cryogen-free dilution refrigerator.

de Wit M, Welker G, Heeck K, Buters FM, Eerkens HJ, Koning G, van der Meer H, Bouwmeester D, Oosterkamp TH.

Rev Sci Instrum. 2019 Jan;90(1):015112. doi: 10.1063/1.5066618.

PMID:
30709182
26.

The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France.

Palominos PE, Gossec L, Kreis S, Hinckel CL, da Silva Chakr RM, Moro ALD, Campbell W, de Wit M, Goel N, Kohem CL, Xavier RM.

Adv Rheumatol. 2018 Oct 22;58(1):33. doi: 10.1186/s42358-018-0036-6.

PMID:
30657095
27.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck A, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Jan 15. pii: jrheum.181123. doi: 10.3899/jrheum.181123. [Epub ahead of print]

PMID:
30647191
28.

The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.

Smith TO, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Dodd S, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Jan 15. pii: jrheum.181194. doi: 10.3899/jrheum.181194. [Epub ahead of print]

PMID:
30647185
29.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Jan 15. pii: jrheum.181081. doi: 10.3899/jrheum.181081. [Epub ahead of print]

PMID:
30647174
30.

Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.

Kelly A, Bartlett SJ, de Wit MP, Beaton DE, Dawson T, Evans V, Gill M, Hassett G, March L, Scholte-Voshaar M, Singh JA, Tong A, Tugwell P, Wong P, Tymms K.

J Rheumatol. 2019 Jan 15. pii: jrheum.181078. doi: 10.3899/jrheum.181078. [Epub ahead of print]

PMID:
30647162
31.

Clinicopathological prognostic indicators of survival and pathological findings in cold-stressed Florida manatees Trichechus manatus latirostris.

Martony M, Hernandez JA, de Wit M, St Leger J, Erlacher-Reid C, Vandenberg J, Stacy NI.

Dis Aquat Organ. 2019 Jan 10;132(2):85-97. doi: 10.3354/dao03306.

32.

Unique role of rheumatology in establishing collaborative relationships in research. Past, present and future of patient engagement.

de Wit M, Adebajo A.

Ann Rheum Dis. 2019 Mar;78(3):293-296. doi: 10.1136/annrheumdis-2018-214387. Epub 2018 Dec 17.

PMID:
30559252
33.

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Callis Duffin K, Tugwell P, Beaton D, Gladman DD.

J Rheumatol. 2018 Dec 15. pii: jrheum.181077. doi: 10.3899/jrheum.181077. [Epub ahead of print]

PMID:
30554154
34.

Youth With Type 1 Diabetes Taking Responsibility for Self-Management: The Importance of Executive Functioning in Achieving Glycemic Control: Results From the Longitudinal DINO Study.

Vloemans AF, Eilander MMA, Rotteveel J, Bakker-van Waarde WM, Houdijk ECAM, Nuboer R, Winterdijk P, Snoek FJ, De Wit M.

Diabetes Care. 2019 Feb;42(2):225-231. doi: 10.2337/dc18-1143. Epub 2018 Dec 14.

PMID:
30552132
35.

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M.

Haematologica. 2019 May;104(5):955-962. doi: 10.3324/haematol.2018.206797. Epub 2018 Dec 4.

36.

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.

Gorlier C, Orbai AM, Puyraimond-Zemmour D, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Tälli S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, de Wit M, Smolen JS, Gossec L.

Ann Rheum Dis. 2019 Feb;78(2):201-208. doi: 10.1136/annrheumdis-2018-214140. Epub 2018 Nov 15.

37.

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.

Dietz A, Wichmann G, Kuhnt T, Pfreundner L, Hagen R, Scheich M, Kölbl O, Hautmann MG, Strutz J, Schreiber F, Bockmühl U, Schilling V, Feyer P, de Wit M, Maschmeyer G, Jungehülsing M, Schroeder U, Wollenberg B, Sittel C, Münter M, Lenarz T, Klussmann JP, Guntinas-Lichius O, Rudack C, Eich HT, Foerg T, Preyer S, Westhofen M, Welkoborsky HJ, Esser D, Thurnher D, Remmert S, Sudhoff H, Görner M, Bünzel J, Budach V, Held S, Knödler M, Lordick F, Wiegand S, Vogel K, Boehm A, Flentje M, Keilholz U.

Ann Oncol. 2018 Oct 1;29(10):2105-2114. doi: 10.1093/annonc/mdy332.

PMID:
30412221
38.

The International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working Group.

Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, Boonen A, Chau J, Courvoisier DS, Curtis JR, Ellis B, Ernestam S, Gossec L, Hale C, Hornjeff J, Leung KYY, Lidar M, Mease P, Michaud K, Mody GM, Ndosi M, Opava CH, Pinheiro GRC, Salt M, Soriano ER, Taylor WJ, Voshaar MJH, Weel AEAM, de Wit M, Wulffraat N, van de Laar MAFJ, Vonkeman HE.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23799. [Epub ahead of print]

PMID:
30358135
39.

The Delphi method-more research please.

Humphrey-Murto S, de Wit M.

J Clin Epidemiol. 2019 Feb;106:136-139. doi: 10.1016/j.jclinepi.2018.10.011. Epub 2018 Oct 21. No abstract available.

PMID:
30352274
40.

Positive Well-Being in Youth With Type 1 Diabetes During Early Adolescence.

Steinberg DM, Anderson BJ, de Wit M, Hilliard ME.

J Early Adolesc. 2018 Nov;38(9):1215-1235. doi: 10.1177/0272431617692444. Epub 2017 Feb 12.

PMID:
30319165
41.

Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study.

Wieringa TH, de Wit M, Twisk JW, Snoek FJ.

BMJ Open Diabetes Res Care. 2018 Oct 1;6(1):e000548. doi: 10.1136/bmjdrc-2018-000548. eCollection 2018.

42.

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators.

N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.

PMID:
30280658
43.

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.

Braess J, Amler S, Kreuzer KA, Spiekermann K, Lindemann HW, Lengfelder E, Graeven U, Staib P, Ludwig WD, Biersack H, Ko YD, Uppenkamp MJ, De Wit M, Korsten S, Peceny R, Gaska T, Schiel X, Behringer DM, Kiehl MG, Zinngrebe B, Meckenstock G, Roemer E, Medgenberg D, Spaeth-Schwalbe E, Massenkeil G, Hindahl H, Schwerdtfeger R, Trenn G, Sauerland C, Koch R, Lablans M, Faldum A, Görlich D, Bohlander SK, Schneider S, Dufour A, Buske C, Fiegl M, Subklewe M, Braess B, Unterhalt M, Baumgartner A, Wörmann B, Beelen D, Hiddemann W; AML-CG.

Leukemia. 2018 Dec;32(12):2558-2571. doi: 10.1038/s41375-018-0268-9. Epub 2018 Oct 1.

44.

Changes in resource partitioning between and within organs support growth adjustment to neighbor proximity in Brassicaceae seedlings.

de Wit M, George GM, Ince YÇ, Dankwa-Egli B, Hersch M, Zeeman SC, Fankhauser C.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):E9953-E9961. doi: 10.1073/pnas.1806084115. Epub 2018 Oct 1.

45.

Development of a standard form for assessing research grant applications from the perspective of patients.

de Wit M, Teunissen T, van Houtum L, Weide M.

Res Involv Engagem. 2018 Sep 3;4:27. doi: 10.1186/s40900-018-0112-4. eCollection 2018.

46.

Sodium Channel SCN3A (NaV1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor Development.

Smith RS, Kenny CJ, Ganesh V, Jang A, Borges-Monroy R, Partlow JN, Hill RS, Shin T, Chen AY, Doan RN, Anttonen AK, Ignatius J, Medne L, Bönnemann CG, Hecht JL, Salonen O, Barkovich AJ, Poduri A, Wilke M, de Wit MCY, Mancini GMS, Sztriha L, Im K, Amrom D, Andermann E, Paetau R, Lehesjoki AE, Walsh CA, Lehtinen MK.

Neuron. 2018 Sep 5;99(5):905-913.e7. doi: 10.1016/j.neuron.2018.07.052. Epub 2018 Aug 23.

PMID:
30146301
47.

Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.

Ferreira RJO, Ndosi M, de Wit M, Santos EJF, Duarte C, Jacobs JWG, Machado PM, van der Heijde D, Gossec L, da Silva JAP.

Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-214199. doi: 10.1136/annrheumdis-2018-214199. [Epub ahead of print] No abstract available.

PMID:
30127056
48.

[Practice Pattern of Systemic Therapy for Urothelial Cancer in Germany - A Survey of the German Cancer Society].

Hupe MC, Merseburger AS, de Wit M, Rexer H, Gschwend JE, Krege S.

Aktuelle Urol. 2018 Aug;49(4):346-354. doi: 10.1055/a-0645-1076. Epub 2018 Aug 7. German.

PMID:
30086593
49.

ISPAD Clinical Practice Consensus Guidelines 2018: Psychological care of children and adolescents with type 1 diabetes.

Delamater AM, de Wit M, McDarby V, Malik JA, Hilliard ME, Northam E, Acerini CL.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:237-249. doi: 10.1111/pedi.12736. No abstract available.

PMID:
30058247
50.

Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands.

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.

J Natl Cancer Inst. 2019 Mar 1;111(3):256-263. doi: 10.1093/jnci/djy104.

PMID:
30020493

Supplemental Content

Loading ...
Support Center